Results 261 to 270 of about 366,889 (322)
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results. [PDF]
Hermans C+17 more
europepmc +1 more source
Abstract A modified controlled‐release sodium valproate formulation (VAL001, test) was compared with an approved enteric‐coated tablet formulation (Absenor, reference). Pharmacokinetics and safety/tolerability were evaluated in healthy subjects to bridge with positive efficacy results from an early‐phase patient trial of valproate in combination with ...
Nikhil Ahuja+8 more
wiley +1 more source
Inter-reader agreement of the BI-RADS CEM lexicon. [PDF]
Zarcaro C+8 more
europepmc +1 more source
Using a Probabilistic Class-Based Lexicon for Lexical Ambiguity Resolution
Detlef Prescher+2 more
openalex +2 more sources
Abstract A pediatric‐friendly powder for oral suspension (PfOS) of tovorafenib, a type II RAF inhibitor, was developed for patients with difficulty swallowing tablets. This open‐label, randomized, phase 1 study (QSC205140) evaluated the taste/palatability of PfOS formulations (n = 12), the relative bioavailability of the PfOS versus tablet formulation,
Yang Zhang+6 more
wiley +1 more source
Open-access network science: Investigating phonological similarity networks based on the SUBTLEX-US lexicon. [PDF]
Alderete J, Mann S, Tupper P.
europepmc +1 more source
Abstract Clascoterone is an androgen receptor inhibitor approved for the treatment of acne vulgaris in patients 12 years of age and older. Here, we report results of 5 phase 1 studies that assessed the pharmacokinetics (PK), safety, and skin irritation and sensitization potential of clascoterone cream 1% in healthy participants and patients with acne ...
Andrea Francesco Daniele Di Stefano+8 more
wiley +1 more source
Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease. [PDF]
Kim J+5 more
europepmc +1 more source
Abstract Imlunestrant (LY3484356) is a next‐generation orally bioavailable selective estrogen receptor degrader being investigated for the treatment of estrogen receptor–positive advanced breast and endometrial cancers. This Phase 1, open‐label, 2‐part study evaluated the disposition and absolute bioavailability of [14C]‐imlunestrant in 16 US‐based ...
Amita Datta‐Mannan+6 more
wiley +1 more source
Semantic enhancement and cross-modal interaction fusion for sentiment analysis in social media. [PDF]
Mu G, Chen Y, Li X, Dai L, Dai J.
europepmc +1 more source